REVERSED 

1600 Biotechnology and Organic Chemistry 

Ex Parte Aoki et al ADAMS 103(a) OBLON, SPIVAK, MCCLELLAND MAIER & NEUSTADT, L.L.P. 

"Evidence that a compound is unexpectedly superior in one of a spectrum of common properties . . . can be enough to rebut a prima facie case of obviousness." In re Chupp, 816 F.2d 643, 646 (Fed. Cir. 1987). 

Chupp, In re, 816 F.2d 643, 2 USPQ2d1437 (Fed. Cir. 1987) . . . . . . .716.01(d), 716.02(a), 2145 

Ex Parte Brahmbhatt LEBOVITZ 103(a) AIR LIQUIDE 

Ex Parte McDevitt et al LEBOVITZ 112(1) FULBRIGHT & JAWORSKI L.L.P. 

Ex Parte Yun et al SCHEINER 102(b) BOZICEVIC, FIELD & FRANCIS LLP 

"[T]he examiner must provide some evidence or scientific reasoning to establish the reasonableness of the examiner’s belief that the functional limitation is an inherent characteristic of the prior art" before the burden is shifted to Applicants to disprove the inherency. Ex parte Skinner, 2 USPQ2d 1788, 1789 (BPAI 1986). 

1700 Chemical & Materials Engineering

Ex Parte Runge et al DELMENDO 102(b)/103(a) KIMBERLY-CLARK WORLDWIDE, INC. 

Ex Parte Mao et al PAK 102(b)/103(a) DUGAN & DUGAN, P.C. 

Ex Parte Champ et al NAGUMO 112(1)/103(a) MARSHALL, GERSTEIN & BORUN LLP 

Ex Parte Chen et al HANLON 103(a) PATTERSON & SHERIDAN, LLP - - APPM/TX 3600 Transportation, Construction, Electronic Commerce, Agriculture, National Security, and License & Review 

Ex Parte Henderson et al TURNER 102(e) CANTOR COLBURN, LLP 

Ex Parte Lahiri TURNER 103(a) Robert V. Wilder 

Ex Parte Wahlbin et al CRAWFORD 103(a) MEYERTONS, HOOD, KIVLIN, KOWERT & GOETZEL, P.C. 

AFFIRMED-IN-PART 

3700 Mechanical Engineering, Manufacturing, and Products & Design 

Ex Parte Laing SONG 102(b)/103(a) RATNERPRESTIA 

Ex Parte Schaller et al McCARTHY 103(a) GREIGG & GREIGG P.L.L.C.